Abstract: A centralized biometric system for verifying the identity of a user over a communications network includes a device that stores biometric information in association with information that identifies users. The system further includes a receiver that receives, from a media content presentation device via a communications network, a biometric sample provided by a user requesting media content from a provider. The provider delivers the media content requested by the user from the communications network to the media content presentation device for receipt by the user contingent upon the identity of the user being verified. The system further includes a processor that compares the biometric sample provided by the user to stored biometric information of the user. The processor verifies the identity of the user upon a sufficient correspondence between the biometric sample provided by the user and the stored biometric information of the user.

Abstract: A centralized biometric system is provided for verifying an individual's identity over a communications network. The centralized biometric system includes a receiver that receives, from a remote communications system, a biometric sample from a party attempting to obtain a service using the remote communications system. The service is provided contingent on authentication of the party as the individual. The system also includes a processor that compares the biometric sample to biometric information obtained from a storage to authenticate the identity of the party as the individual. The receiver and the processor are within a centralized system in the communications network.

Abstract: The invention is directed to purified and isolated novel RGL polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.

Abstract: The invention is directed to purified and isolated novel RGL2 polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above.

Abstract: In one aspect, the invention relates to processes for producing substantially free-flowing shapes of macrocyclic oligoester, wherein the freshly-shaped macrocyclic oligoester is maintained at elevated temperature for a sufficient time. In certain embodiments, the shapes are heated in water, thereby avoiding agglomeration during the heating process itself. In another aspect, the invention relates to processes for removing solvent from a solution of macrocyclic oligoester using elevated temperature, reduced pressure, or both, thereby obviating the need for an anti-solvent to precipitate the macrocyclic oligoester from the solution. Other aspects of the invention related to shaping of macrocyclic oligoesters are presented as well.

Abstract: Processes for isolating, formulating, and shaping macrocyclic oligesters were developed which allow efficient production of macrocyclic oligoesters substantially free from solvent, which may include additives, fillers, and catalysts.

Abstract: A change management system coordinates information of a transaction tool managed by a transaction tool management system. The system includes a receiver that receives, over a communications network, activity information and/or lifecycle event information for the transaction tool. The system also includes a storage that stores the received information. Additionally, the system includes a processor that manages a change in a status of the transaction tool based on the received information.

Abstract: A method is provided for repairing a driven compressor housing including a bore having an inner surface configured to engage a shaft-mounted knife seal. The method includes the steps of removing material from the bore inner surface, press-fitting a sleeve into the bore, and plasma-spraying an abradable coating onto the bore inner surface.

Abstract: This invention relates to a gene encoding RTVP that has been shown to be up-regulated by p53 using differential display-PCR and subsequently by co-transfection studies. RTVP-1 mRNA is abundant in normal mouse and human prostatic epithelial cells and primary tumors, but is significantly down regulated in metastatic mouse and human prostate cancer. In prostate cancer cells overexpression of the mouse RTVP-1 gene (mRTVP-1) induced apoptosis that was accompanied by increased caspase 8, 9 and 3 activities. mRTVP-1-stimulated apoptosis was also associated with increased levels of bax, bad and activated BID; reduced levels of bcl-2 and bcl-XL; and cytosolic cytochrome c accumulation. Adenoviral-vector-mediated mRTVP-1 expression lead to potent growth suppression and antimetastatic activities in an orthotopic mouse model of prostate cancer in vivo. These therapeutic activities were associated with anti-angiogenic effects and importantly a local and systemic immune response.

Abstract: A system is provided for managing a transaction tool for an individual. The system includes a receiver that receives a request from the individual to initiate a process for managing the transaction tool. A processor analyzes the request from the individual and dynamically selects, based upon the requested process, at least one authentication method to be used for authenticating the identity of the individual before the request can be honored. The selected authentication method(s) are used to verify the identity of the individual.

Abstract: A system is provided for verifying an identity of a calling party. The system includes a storage that stores voice sample information in association with information that identifies an individual. The system also includes a receiver that receives, from a communications platform called by the calling party, a request to authenticate the identity of the calling party as the individual, using a digital audio sample packetized according to voice over internet protocol and obtained from the calling party during the call. Additionally, the system includes a processor that compares the digital audio sample to the voice sample information to authenticate the identity of the calling party as the individual.

Abstract: A centralized biometric system is provided for verifying an individual's identity over a communications network. The system includes a storage that stores biometric information in association with information that identifies an individual. The system also includes a receiver that receives, from one of a communications device and a network communications platform, a biometric sample from a party attempting to obtain a service from the one of the communications device and the network communications platform. The service is provided contingent on authentication of the party as the individual. The system also includes a processor that compares the biometric sample to the biometric information to authenticate the identity of the party as the individual.

Abstract: A scanner discovers digital certificates by scanning an address range. The scanner scans the address range to determine whether a digital certificate has been installed for each address in the address range. The scanner receives digital certificate information when the digital certificate has been installed for an address. The address range that is scanned may include addresses associated with an installed digital certificate and addresses not associated with an installed digital certificate.

Abstract: Email can be securely stored using a secure record management system. An encrypted email is received at the secure record management system. The received email is a duplicated copy of a transmitted email and is decryptable by the secure record management system. The received email is processed and providing to an archive for archiving.

Abstract: A display device includes a first communication port communicating with a host device, a second communication port communicating with plural slave devices, and a processor circuit including a processor, an interface to the first and second ports and a display. A communication routine cooperates with the processor circuit. The routine includes a first mode of operation that receives a first message from the host device to the first port and repeats the same from the second port to a first slave device, and receives a second message from the first slave device to the second port and repeats the same from the second port to the host device. A second mode interrupts the first mode, sends third messages from the second port to a second slave device, receives fourth messages including information from the second slave device to the second port, and outputs the information to the display.

Abstract: Acid impurities, such as carboxylic acid-terminated polymers, are removed from macrocyclic oligoesters with ion exchange resins, resulting in macrocyclic oligoesters that are substantially free of acid impurities. The ion exchange resins can be regenerated anew and reused by washing the resins with various wash solutions. Macrocyclic oligoesters substantially free of acid impurities polymerize to much higher molecular weight polyesters than macrocyclic oligoesters containing acid impurities.

Abstract: The present invention provides methods and assays for screening and identifying agents that will be useful in the treatment and prevention of neoplastic disorders. The methods and assays of the present invention are particularly useful for identifying therapeutic agents for steroid sensitive neoplastic disorders such as prostate cancer.

Abstract: This invention relates to a gene encoding RTVP that has been shown to be up-regulated by p53 using differential display-PCR and subsequently by co-transfection studies. RTVP-1 mRNA is abundant in normal mouse and human prostatic epithelial cells and primary tumors, but is significantly down regulated in metastatic mouse and human prostate cancer. In prostate cancer cells overexpression of the mouse RTVP-1 gene (mRTVP-1) induced apoptosis that was accompanied by increased caspase 8, 9 and 3 activities. mRTVP-1-stimulated apoptosis was also associated with increased levels of bax, bad and activated BID; reduced levels of bcl-2 and bcl-XL; and cytosolic cytochrome c accumulation. Adenoviral-vector-mediated mRTVP-1 expression lead to potent growth suppression and antimetastatic activities in an orthotopic mouse model of prostate cancer in vivo. These therapeutic activities were associated with anti-angiogenic effects and importantly a local and systemic immune response.

Abstract: A logical gate and a comparator are used to detect page boundaries in a data stream. A current address and a predetermined page size, that is an integer power of 2, are compared using a Boolean logic gate such as AND or XOR to detect a page boundary in a data stream. The output from the Boolean logic gate is compared to a predetermined value to cause a signal to be generated, indicating the end of the page.

Abstract: Serum cav-1 is disclosed as a biomarker for prostate cancer that has the power to differentiate between prostate cancer and BPH patients.